Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine effects on right ventricular contractile reserve and myocardial oxygen consumption in pulmonary arterial hypertension
NL-OMON50331Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dobutamine in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Vrije University Medical Center. Primary endpoints: Myocardial oxygen consumption and Right ventricular contractility. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
dobutamine
03
Conditions
pulmonary arterial hypertension (PAH)chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on NL-OMON50331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50331.